Tandem Diabetes Care, Inc.
TNDM
$21.01
$0.281.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.01B | 1.00B | 982.95M | 940.20M | 854.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.01B | 1.00B | 982.95M | 940.20M | 854.35M |
| Cost of Revenue | 470.99M | 475.35M | 469.64M | 450.63M | 428.94M |
| Gross Profit | 536.01M | 526.37M | 513.31M | 489.57M | 425.41M |
| SG&A Expenses | 428.84M | 420.04M | 404.68M | 389.82M | 371.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.10B | 1.09B | 1.07B | 1.04B | 990.06M |
| Operating Income | -89.80M | -93.03M | -91.94M | -99.13M | -135.70M |
| Income Before Tax | -204.94M | -202.41M | -174.43M | -91.87M | -123.20M |
| Income Tax Expenses | -1.57M | 3.04M | 9.44M | 4.16M | 3.59M |
| Earnings from Continuing Operations | -203.37 | -205.45 | -183.87 | -96.03 | -126.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -203.37M | -205.45M | -183.87M | -96.03M | -126.78M |
| EBIT | -89.80M | -93.03M | -91.94M | -99.13M | -135.70M |
| EBITDA | -72.38M | -75.89M | -75.07M | -82.52M | -119.31M |
| EPS Basic | -3.05 | -3.09 | -2.78 | -1.47 | -1.94 |
| Normalized Basic EPS | -0.90 | -0.88 | -0.80 | -0.83 | -1.17 |
| EPS Diluted | -3.05 | -3.09 | -2.78 | -1.47 | -1.94 |
| Normalized Diluted EPS | -0.90 | -0.88 | -0.80 | -0.83 | -1.17 |
| Average Basic Shares Outstanding | 267.05M | 264.93M | 262.88M | 261.80M | 261.23M |
| Average Diluted Shares Outstanding | 267.26M | 265.15M | 263.09M | 262.02M | 261.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |